Levetiracetam Plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children With Epilepsy. Braz. J. Pharm. Sci. 2023, 59, e21414. https://doi.org/10.1590/s2175-97902023e21414.